En Es
Categories

EUROIMMUN AG

Produces reagents for medical laboratory diagnostics, including test systems for the determination of various antibodies in patient serum in the diagnosis of autoimmune diseases, infectious diseases and allergies
Gold member
Products Covid-19Summary
Close

Covid-19 EUROIMMUN AG

Clinical Laboratory

SARS-CoV-2 sVNT Test
SARS-CoV-2-NeutraLISA

The SARS-CoV-2-NeutraLISA is a surrogate virus neutralization test (sVNT) for the semi-quantitative detection of neutralizing antibodies inhibiting the binding of SARS-CoV-2 S1/RBD to ACE2 receptors of the host cells. It supports the evaluation of the immune response after SARS-CoV-2 infection or vaccination using S1/RBD-based vaccines.
More details

SARS-CoV-2 IGRA
SARS-CoV-2 IGRA

The SARS-CoV-2 IGRA is an interferon-gamma release assay (IGRA) for the quantitative determination of the IFN-γ release of SARS-CoV-2-specific T cells.
More details

Nucleic Acid Extractor
Pre-NAT II

The Pre-NAT II allows fully automated high-throughput sample preparation for molecular genetic diagnostics, consisting of nucleic acid extraction and subsequent pipetting of the PCRs. In this way, up to 96 primary samples from various source materials are prepared efficiently, safely and without any manual intermediate steps for subsequent PCR-based tests, e.g. EUROArray and EURORealTime.
More details

SARS-CoV-2 PCR Test
EURORealTime SARS-CoV-2

EURORealTime SARS-CoV-2 is a PCR test for the specific detection ofSARS-CoV-2, including the new variants VOC 202012/01 (B.1.1.7 lineage) and 501.V2 (B.1.351 lineage). The test enables quick and simple pathogen detection by means of reverse transcription and real-time PCR in one step, and has high sensitivity due to simultaneous detection of two SARS-CoV-2 target sequences.
More details

SARS-CoV-2/Influenza A/B PCR Test
EURORealTime SARS-CoV-2/Influenza A/B

EURORealTime SARS-CoV-2/Influenza A/B is a reliable PCR test for the specific detection of SARS-CoV-2, including the new variants VOC202012/01 (B.1.1.7 lineage) and 501.V2 (B.1.351 lineage) as well as of influenza virus types A and B. It enables quick and simple pathogen detection by means of reverse transcription and real-time PCR in one step, and is intended for differential diagnostic clarification of symptoms that can be associated with COVID-19 as well as influenza.
More details

SARS-CoV-2 Antigen ELISA
SARS-CoV-2 Antigen ELISA

SARS-CoV-2 Antigen ELISA is a laboratory diagnostic test for the direct detection of SARS-CoV-2 by semi-quantitative determination of the virus-specific nucleocapsid protein in swab samples from the upper respiratory tract. Designed to support acute diagnostics, especially during a COVID-19 outbreak, the test is based on the established ELISA method, making it suitable for every diagnostic laboratory and is fully automatable.
More details

Anti-SARS-CoV-2 ELISA IgG
Anti-SARS-CoV-2 ELISA IgG

The Anti-SARS-CoV-2 ELISA IgG is intended for the specific detection of IgG against SARS-CoV-2 using the S1 domain of the spike protein, including the immunologically relevant receptor binding domain (RBD). Its excellent performance and good correlation with neutralization tests has been confirmed in external studies, and the fully automatable test has been validated for serum, plasma and dried capillary blood as the sample material.
More details

Anti-SARS-CoV-2 ELISA (IgG)
Anti-SARS-CoV-2 QuantiVac ELISA (IgG)

The Anti-SARS-CoV-2 QuantiVac ELISA (IgG) is a quantitative ELISA for the determination of concentration of IgG antibodies against the S1 antigen (incl. RBD) of SARS-CoV-2 in a broad linear range (using a 6-point calibration curve). Validated for serum, plasma and dried capillary blood as sample material, the test enables issuing of results in standardized units and demonstrates very good agreement of results in comparison with different neutralization tests.
More details

Anti-SARS-CoV-2 NCP ELISA (IgG)
Anti-SARS-CoV-2 NCP ELISA (IgG)

Anti-SARS-CoV-2 NCP ELISA (IgG) is intended for the sensitive detection of IgG against SARS-CoV-2 using the nucleocapsid protein, the antigen with the strongest immune dominance in the coronavirus family. The fully automatable test offers optimized specificity of the ELISA due to the use of a modified nucleocapsid protein (NCP) that only contains diagnostically relevant epitopes and has been validated for serum, plasma and dried capillary blood as sample material.
More details

Anti-SARS-CoV-2 NCP ELISA (IgM)
Anti-SARS-CoV-2 NCP ELISA (IgM)

Anti-SARS-CoV-2 NCP ELISA (IgM) is intended for the sensitive detection of IgM against SARS-CoV-2 using the nucleocapsid protein, the antigen with the strongest immune dominance in the coronavirus family. It offers optimized specificity of the ELISA due to the use of a modified nucleocapsid protein (NCP) that only contains diagnostically relevant epitopes, and allows for fully automated processing and evaluation.
More details

Anti-SARS-CoV-2 ELISA IgA
Anti-SARS-CoV-2 ELISA IgA

Anti-SARS-CoV-2 ELISA IgA is a sensitive ELISA test for the determination of IgA antibodies against SARS-CoV-2 with optimized specificity due to the use of sample buffer PLUS. It makes use of the spike protein domain S1 as the antigen for monitoring the immune response after positive direct pathogen detection, and makes fully automated processing and evaluation possible.
More details

Blood Collection Set
Blood Collection Set

Euroimmun’s Blood Collection Set for COVID-19 diagnostics using dried capillary blood enables convenient sample collection for the company’s CE-marked ELISAs for the detection of anti-SARS-CoV-2 antibodies (IgG). The use of dried blood spots (DBS) as sample material reduces the blood collection to a quick prick into the fingertip, sparing patients the burdensome and stressful collection of venous blood. The blood spot is brought onto the blood collection card and after drying, it can be sent to the laboratory immediately. All the required materials are included in the EUROIMMUN Blood Collection Set, including alcohol pad, lancet, blood collection card and plasters, while the blood collection cards can also be purchased separately.
More details

ELISA Processor
EUROIMMUN Analyzer I-2P

EUROIMMUN Analyzer I-2P enables a quick and simple, but also a secure routine operation, owing to the automatic recognition and allocation of reagents and the import of QC data via Data Matrix codes. Designed for low to medium sample volumes, a further quality feature of EUROIMMUN Analyzer I-2P is the optionally available climate control unit, which ensures constant incubation conditions - regardless of fluctuating or excessively high laboratory temperatures.
More details

COVID-19 PCR and ELISAs
COVID-19 PCR and ELISAs

EUROIMMUN’s portfolio for COVID-19 diagnostics includes the EURORealTime SARS-CoV-2 for sensitive direct virus detection, as well as ELISAs based on spike protein domain S1 (IgG, IgA) or modified nucleocapsid protein (NCP, IgG). The IgG ELISAs demonstrate specificities of 99.6% and 99.8% and sensitivities of 94.4% and 94.6%, respectively. The antibody detection can also be performed using dried blood spots taken with the Blood Collection Set. The ELISAs can be processed fully automatically, for example on the EUROLabWorkstation ELISA. All the tests are CE marked.
More details
Close

About EUROIMMUN AG

Number of Employees: 1000+
Year of Establishment: 1987
Produces reagents for medical laboratory diagnostics, including test systems for the determination of various antibodies in patient serum in the diagnosis of autoimmune diseases, infectious diseases and allergies
FaceBook Twitter Google+ Linked in
SARS-CoV-2 PCR Test

SARS-CoV-2 PCR Test

Model: EURORealTime SARS-CoV-2
Request Information

Description:

EURORealTime SARS-CoV-2 is a PCR test for the specific detection ofSARS-CoV-2, including the new variants VOC 202012/01 (B.1.1.7 lineage) and 501.V2 (B.1.351 lineage). The test enables quick and simple pathogen detection by means of reverse transcription and real-time PCR in one step, and has high sensitivity due to simultaneous detection of two SARS-CoV-2 target sequences.

Features Specifications

Features

• CE-marked PCR test for specific detection of SARS-CoV-2
• Quick and simple pathogen detection by means of reverse transcription and real-time PCR in one step
• High sensitivity due to simultaneous detection of two SARS-CoV-2 target sequences
• Only one reaction per sample Request Information

Specifications

• Test principle: Reverse transcription of the SARS-CoV-2 genome followed by PCR amplification and real-time detection using specific primers and probes
• Test procedure: Reverse transcription and real-time PCR in one test (approx. 90 min)
• Reagents: Ready for use
• Controls: Internal inhibition and extraction control (RNA), SARS-CoV-2 positive control (RNA), negative control
• CE-IVD mark: Test system validated for the following real-time PCR cyclers: LightCycler® 480 II (Roche), 7500 FastReal-Time PCR Instrument (Applied Biosystems), CFX 96 Touch (Bio-Rad), RotorGene Q (Qiagen), qTower3 (Analytik Jena); other devices should be validated individually by the user.
• Test kit format: 25, 50, 100, 200 or 1000 reactions Request Information

Send A Message To This Supplier

* Required Information
* Email
To
EUROIMMUN AG (SARS-CoV-2 PCR Test)
* Message

Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions